|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400089956 |
|
最近更新日期: Date of Last Refreshed on: |
2024-09-20 11:00:03 |
|
注册时间: Date of Registration: |
2024-09-20 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
基于IKAP模式的出院准备度护理干预在乳腺癌病人配偶或子女的应用研究 |
|
Public title: |
Application of IKAP model based on discharge readiness nursing intervention in spouses or children of breast cancer patients |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于IKAP模 式的出院准备度护理干预在乳腺癌病人配偶或子女的应用研究 |
|
Scientific title: |
Application of IKAP model based on discharge readiness nursing intervention in spouses or children of breast cancer patients |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王丽 |
研究负责人: |
王丽 |
|
Applicant: |
Li Wang |
Study leader: |
Li Wang |
|
申请注册联系人电话: Applicant telephone: |
+86 138 2353 5516 |
研究负责人电话: Study leader's telephone: |
+86 138 2353 5516 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1176265298@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
1176265298@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广东省深圳市福田区莲花街道1120号北京大学深圳医院外科楼5楼肿瘤科 |
研究负责人通讯地址: |
广东省深圳市福田区莲花街道1120号北京大学深圳医院外科楼5楼肿瘤科 |
|
Applicant address: |
Department of Oncology, 5th Floor, Surgical Building, Shenzhen Hospital, Peking University, No.1120 Lianhua Street, Futian District, Shenzhen City, Guangdong Province |
Study leader's address: |
Department of Oncology, 5th Floor, Surgical Building, Shenzhen Hospital, Peking University, No.1120 Lianhua Street, Futian District, Shenzhen City, Guangdong Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
北京大学深圳医院 |
||
|
Applicant's institution: |
Peking University Shenzhen Hospital |
||
|
研究负责人所在单位: |
北京大学深圳医院 |
||
|
Affiliation of the Leader: |
Peking University Shenzhen Hospital |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
北大深医伦审(研)[2024]第(101)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
北京大学深圳医院科研伦理委员会 |
||
|
Name of the ethic committee: |
Research Ethics Committee of Peking University Shenzhen Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-06-27 00:00:00 |
||
|
伦理委员会联系人: |
陈嘉仪 |
||
|
Contact Name of the ethic committee: |
Jiayi Chen |
||
|
伦理委员会联系地址: |
广东省深圳市福田区莲花街道1120号北京大学深圳医院综合楼科研伦理办公室 |
||
|
Contact Address of the ethic committee: |
Office of Research Ethics, Comprehensive Building, Shenzhen Hospital, Peking University, No.1120 Lianhua Street, Futian District, Shenzhen City, Guangdong Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 755 8392 3333 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
北京大学深圳医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Peking University Shenzhen Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广东省深圳市福田区莲花街道1120号北京大学深圳医院外科楼5楼肿瘤科 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Department of Oncology, 5th Floor, Surgical Building, Shenzhen Hospital, Peking University, No.1120 Lianhua Street, Futian District, Shenzhen City, Guangdong Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
深圳市科技创新委员会 |
||||||||||||||||||||||
|
Source(s) of funding: |
Shenzhen Science and Technology Innovation Commission |
||||||||||||||||||||||
|
Target disease: |
Breast cancer |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
乳腺癌病人治疗过程漫长复杂,病人在医院经过短暂治疗后,出院时仍需继续康复和照护,在常规护理的出院准备中,我们通常聚焦于提高病人的自我照顾能力,而忽略了提高家属照顾病人的能力,但实际上配偶或子女确是乳腺癌病人最重要的照护者和家庭支持来源。但研究发现,乳腺癌病人配偶或子女在照顾病人的过程中,在面临处理病人术后康复锻炼、放化疗治疗后不良反应应对、情感支持、家庭结构重新调整如性适应、家务管理、子女照顾等问题时,却无法给予更好地照顾,严重阻碍病人居家康复,影响病人的心理健康和生活质量。在出院准备度的理念提出后,国内外研究已证明,发挥有效的出院准备度,病人能更顺利地实现医院向家庭的过渡,出院后有效应对能力较强,病人居家康复效果更理想,非计划再入院率较低,可节约医疗资源,减轻病人及配偶与子女的负担。此外,多项研究表明,IKAP模式的护理干预同样可有效的提高病人及照护者照护能力,提高病人生活质量,尽快地回归家庭和适应社会角色。但两者结合二者联合应用于乳腺癌病人配偶或子女出院准备度能否满足乳腺癌病人的信息需求,减少其并发症,提高其生活质量,促进其更好的回归家庭角色及适应社会角色,则需进一步探讨。本课题拟开展基于IKAP模式的出院准备度护理干预在乳腺癌病人配偶或子女的研究项目,对提高乳腺癌病人生活质量作出以下可期的贡献: 1.明确IKAP模式应用于乳腺癌病人配偶或子女的出院准备度的有效性; 2.阐明基于IKAP模式的出院准备度护理干预在乳腺癌病人配偶或子女的应用是否为促进病人居家康复、提高生活质量的重要科学手段。 |
||||||||||||||||||||||
|
Objectives of Study: |
The treatment process of breast cancer patients is long and complex, and patients still need to continue rehabilitation and care when discharged from the hospital after a short treatment. In the preparation for discharge of conventional care, we usually focus on improving the self-care ability of patients, while ignoring the ability of family members to take care of patients. In fact, spouses or children are the most important caregivers and family support sources for breast cancer patients. However, studies have found that spouses or children of breast cancer patients cannot provide better care in the process of taking care of patients, when faced with problems such as postoperative rehabilitation exercise, adverse reactions after radiotherapy and chemotherapy treatment, emotional support, family structure readjust such as sexual adaptation, household management, and child care, which seriously hinder patients' home rehabilitation. Affecting patients' mental health and quality of life. After the concept of discharge readiness was put forward, domestic and foreign studies have proved that patients with effective discharge readiness can realize the transition from hospital to family more smoothly, have stronger effective coping ability after discharge, have better home rehabilitation effect of patients, and have lower unplanned readmission rate, which can save medical resources and reduce the burden of patients, spouses and children. In addition, a number of studies have shown that IKAP mode of nursing intervention can also effectively improve the caring ability of patients and caregivers, improve the quality of life of patients, and return to the family and adapt to the social role as soon as possible. However, whether the combined application of the two methods in the discharge readiness of spouses or children of breast cancer patients can meet the information needs of breast cancer patients, reduce their complications, improve their quality of life, and promote their better return to family roles and adapt to social roles needs further discussion. This project intends to carry out a research project on discharge readiness nursing intervention based on IKAP model in spouses or children of breast cancer patients, and make the following predictable contributions to improving the quality of life of breast cancer patients: 1. To determine the effectiveness of the IKAP model for the discharge readiness of spouses or children of breast cancer patients; 2. Clarify whether the application of IKAP model based discharge readiness nursing intervention in spouses or children of breast cancer patients is an important scientific means to promote home rehabilitation of patients and improve quality of life. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①照顾对象限定为首次或第二次入院(住院次数>2次的乳腺癌病人的照护者已经基本了解和掌握疾病治疗和照护的相关内容,会干扰临床数据分析)行肿瘤治疗的乳腺癌病人、预计生存期≥6个月;②配偶、子女年龄(18-65)周岁;③自愿参加本研究并能全程配合,签署知情同意书;④能正常沟通;⑤承担病人的主要照顾责任,照顾时长>40小时/每周,预计照顾时间≥6个月。⑥配偶、子女健康状况良好。 |
||||||||||||||||||||||
|
Inclusion criteria |
① The object of care is limited to the first or second admission of breast cancer patients (the caregiver of breast cancer patients with more than 2 inpatient times has a basic understanding and mastery of the relevant contents of disease treatment and care, which will interfere with clinical data analysis), and the expected survival time is ≥6 months; ② Spouse and children (18-65 years old); ③ Volunteer to participate in the study and be able to cooperate throughout the study, sign the informed consent; ④ can communicate normally; ⑤ Take the main responsibility for the care of patients, care time > 40 hours/week, expected care time ≥6 months. ⑥ Spouses and children are in good health. |
||||||||||||||||||||||
|
排除标准: |
①病人或照护者既往有精神类疾病或精神类家族史;②病人合并有其他严重疾病;③照顾对象多于1人;④照顾者有严重基础疾病。 |
||||||||||||||||||||||
|
Exclusion criteria: |
① The patient or caregiver has a previous psychiatric illness or family history of psychiatric illness; ② The patient has other serious diseases; ③ More than one person to take care of; ④ The caregiver has a serious underlying disease. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-07-01 00:00:00至 To 2025-11-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-07-01 00:00:00 至 To 2025-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由项目实施者按照随机数字表法随机分组,把入组研究对象分成对照组和干预组;将两组研究对象分别安置在病区两端的病房中,确保同一病房的研究对象均在同一研究组,避免串组现象。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
According to the random number table method, the subjects were randomly divided into control group and intervention group. The two groups of subjects were placed in the wards at both ends of the ward to ensure that the subjects in the same ward were in the same study group to avoid the phenomenon of tandem groups. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究完成六个月后可联系主要研究者邮箱获得 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Available six months after completion of the study by contacting the principal investigator's email address. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
EDC |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |